Intact synaptic function and plasticity are fundamental prerequisites to a healthy brain. Therefore, synaptic proteins are one of the major targets for drugs used as neuro-chemical therapeutics. Unfortunately, the majority of drugs is not able to cross the blood–brain barrier (BBB) and is therefore distributed within the CNS parenchyma. Here, we report the development of novel biodegradable Nanoparticles (NPs), made of poly-lactide-co-glycolide (PLGA) conjugated with glycopeptides that are able to cross the BBB and deliver for example Zn2+ ions. We also provide a thorough characterization of loaded and unloaded NPs for their stability, cellular uptake, release properties, toxicity, and impact on cell trafficking. Our data reveal that these NPs are biocompatible, and can be used to elevate intracellular levels of Zn2+. Importantly, by engineering the surface of NPs with antibodies against NCAM1 and CD44, we were able to selectively target neurons or glial cells, respectively. Our results indicate that these biodegradable NPs provide a potential new venue for the delivery Zn2+ to the CNS and thus a means to explore the influence of altered zinc levels linked to neuropsychological disorders such as depression.

Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences / Andreas M., Grabrucker; Craig C., Garner; Tobias M., Boeckers; Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni. - In: PLOS ONE. - ISSN 1932-6203. - ELETTRONICO. - 6:(2011), pp. e17851-e17851. [10.1371/journal.pone.0017851]

Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences.

BONDIOLI, Lucia;RUOZI, Barbara;FORNI, Flavio;VANDELLI, Maria Angela;TOSI, Giovanni
2011

Abstract

Intact synaptic function and plasticity are fundamental prerequisites to a healthy brain. Therefore, synaptic proteins are one of the major targets for drugs used as neuro-chemical therapeutics. Unfortunately, the majority of drugs is not able to cross the blood–brain barrier (BBB) and is therefore distributed within the CNS parenchyma. Here, we report the development of novel biodegradable Nanoparticles (NPs), made of poly-lactide-co-glycolide (PLGA) conjugated with glycopeptides that are able to cross the BBB and deliver for example Zn2+ ions. We also provide a thorough characterization of loaded and unloaded NPs for their stability, cellular uptake, release properties, toxicity, and impact on cell trafficking. Our data reveal that these NPs are biocompatible, and can be used to elevate intracellular levels of Zn2+. Importantly, by engineering the surface of NPs with antibodies against NCAM1 and CD44, we were able to selectively target neurons or glial cells, respectively. Our results indicate that these biodegradable NPs provide a potential new venue for the delivery Zn2+ to the CNS and thus a means to explore the influence of altered zinc levels linked to neuropsychological disorders such as depression.
6
e17851
e17851
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences / Andreas M., Grabrucker; Craig C., Garner; Tobias M., Boeckers; Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni. - In: PLOS ONE. - ISSN 1932-6203. - ELETTRONICO. - 6:(2011), pp. e17851-e17851. [10.1371/journal.pone.0017851]
Andreas M., Grabrucker; Craig C., Garner; Tobias M., Boeckers; Bondioli, Lucia; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni
File in questo prodotto:
File Dimensione Formato  
PlosOne, Grabrucker et al., 2011, 6(3), e17851.pdf

accesso aperto

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 2.29 MB
Formato Adobe PDF
2.29 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/648494
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 38
social impact